门诊肿瘤外科中心加速康复外科项目的实施
结果显示,ERAS实施后PONV挽救治疗率下降、TIVA使用增加、术中阿片类药物用量减少、首次口服阿片类时间缩短,但术后阿片类药物总消耗量无临床意义的改变。
要点
- ERAS在门诊肿瘤外科中心可行,PONV挽救治疗和术中阿片用量减少。
- TIVA使用增加,首次口服阿片时间缩短,但术后阿片总消耗未显著改变。
- 缺乏对照,需进一步研究评估ERAS与结局改善的关联。
核心结论
- 在门诊手术中心实施ERAS是可行的,但缺乏对照,需进一步研究评估ERAS与结局改善的关联。
主要发现
- 乳房切除术的PONV挽救治疗率下降28%(95%CI -36至-22)。
- 乳房切除术和子宫切除术的TIVA使用分别增加28%(95%CI 20-40)和58%(95%CI 46-76)。
- 所有手术的术中阿片类药物总用量随时间减少。
- 所有手术的首次口服阿片时间缩短,甲状腺切除术缩短0.96小时(95%CI 2.1-1.4),子宫切除术缩短3.3小时(95%CI 4.5至-1.7)。
- 任何手术的术后阿片类药物总消耗量无临床意义的改变。
临床怎么用
- 在门诊肿瘤外科中心可实施以预防PONV、多模式镇痛和减少阿片使用为核心的ERAS项目。
- 通过持续反馈和员工教育可能逐步改善ERAS依从性和结局。
- 需注意本研究为质量改进项目,结果需谨慎解读。
局限性
- 研究未设置同期对照或干预前对照,无法确定ERAS实施与结局改善的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We describe the implementation of enhanced recovery after surgery (ERAS) programs designed to minimize postoperative nausea and vomiting (PONV) and pain and reduce opioid use in patients undergoing selected procedures at an ambulatory cancer surgery center. Key components of the ERAS included preoperative patient education regarding the postoperative course, liberal preoperative hydration, standardized PONV prophylaxis, appropriate intraoperative fluid management, and multimodal analgesia at all stages. METHODS: We retrospectively reviewed data on patients who underwent mastectomy with or without immediate reconstruction, minimally invasive hysterectomy, thyroidectomy, or minimally invasive prostatectomy from the opening of our institution on January 2016 to December 2018. Data collected included use of total intravenous anesthesia (TIVA), rate of PONV rescue, time to first oral opioid, and total intraoperative and postoperative opioid consumption. Compliance with ERAS elements was determined for each service. Quality outcomes included time to first ambulation, postoperative length of stay (LOS), rate of reoperation, rate of transfer to acute care hospital, 30-day readmission, and urgent care visits ≤30 days. RESULTS: We analyzed 6781 ambulatory surgery cases (2965 mastectomies, 1099 hysterectomies, 680 thyroidectomies, and 1976 prostatectomies). PONV rescue decreased most appreciably for mastectomy (28% decrease; 95% confidence interval [CI], -36 to -22). TIVA use increased for both mastectomies (28%; 95% CI, 20-40) and hysterectomies (58%; 95% CI, 46-76). Total intraoperative opioid administration decreased over time across all procedures. Time to first oral opioid decreased for all surgeries; decreases ranged from 0.96 hours (95% CI, 2.1-1.4) for thyroidectomies to 3.3 hours (95% CI, 4.5 to -1.7) for hysterectomies. Total postoperative opioid consumption did not change by a clinically meaningful degree for any surgery. Compliance with ERAS measures was generally high but varied among surgeries. CONCLUSIONS: This quality improvement study demonstrates the feasibility of implementing ERAS at an ambulatory surgery center. However, the study did not include either a concurrent or preintervention control so that further studies are needed to assess whether there is an association between implementation of ERAS components and improvements in outcomes. Nevertheless, we provide benchmarking data on postoperative outcomes during the first 3 years of ERAS implementation. Our findings reflect progressive improvement achieved through continuous feedback and education of staff.
引用
- Afonso AM, McCormick PJ, Assel MJ, et al. Enhanced Recovery Programs in an Ambulatory Surgical Oncology Center. Anesth Analg. 2021. PMID: 34784326. doi:10.1213/ANE.0000000000005356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。